What's breaking now, across thousands of outlets.
Bausch + Lomb’s dual-action drop for dry eye failed a Phase 2 study, the company exclusively told Endpoints News on Monday. But CEO Brent Saunders claims it was a "better outcome than we had ever hoped ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- Relatively low levels of prenatal exposure to organophosphate pesticides showed no relationship with social communication problems and other traits related to autism in children…
The Queensland grandfather was diagnosed with motor neurone disease 29 years ago. He celebrated his 90th birthday last month.
Researchers at Columbia University have discovered a new type of cell that protects lung cancers from attacks by the immune system.
A recent study found that a mitochondrial protein in the brain regulates how mice consume dietary fat. Lacking this protein in appetite-controlling neurons led to overeating and severe obesity, with…
(MedPage Today) -- Knowing someone who had attempted suicide was associated with subsequent attempts in teens and young adults, a cohort study suggested.
Improving and maintaining woodlands in deprived communities is linked to reduced antidepressant and anti-anxiety medication use, research suggests.
